Comments
Shares of Lupin fell as much as 7.7 per cent to its lowest since August 8, 2014.
At about 10.20 am, the stock was down 5.75 per cent or Rs 70.65 at Rs 1,157 on the BSE.
The pharma company posted a 49 per cent fall in consolidated net profit for the March quarter, missing analysts' estimates.
Lupin also said that it expects more pricing pressure in the United States and was currently seeing price erosion in the high single digits.
“US business will continue to see pressure in FY18 and growth will be a challenge led by increased competition in key products and elevated pricing pressure,” analysts at Jefferies said in their report.
The stock has falled 17.4 per cent this year as of Wednesday's close.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.